Pfizer plans to test a third dose of its COVID vaccine on infants and young children

life-tips
A child, with parent in tow, arrives to receive the Pfizer COVID-19 vaccine for children 5 to 11 years old at London Middle School in Wheeling, Ill., last month.

Pfizer and BioNTech, which produced the first COVID-19 vaccine authorized in the U.S., say they will expand ongoing trials to include a third dose for children as young as 6 months old.

(Image credit: Nam Y. Huh/AP)

Share:

Post a Comment

Designed by OddThemes | Distributed by Blogger Themes